-
1
-
-
0030695173
-
Renal cell carcinoma: recent progress and future directions
-
Mulders P., Figlin R., deKernion J.B., et al. Renal cell carcinoma: recent progress and future directions. Cancer Res 57 (1997) 5189
-
(1997)
Cancer Res
, vol.57
, pp. 5189
-
-
Mulders, P.1
Figlin, R.2
deKernion, J.B.3
-
2
-
-
33644947935
-
Cytokine therapy: a standard of care for metastatic renal cell carcinoma?
-
Hutson T.E., and Quinn D.I. Cytokine therapy: a standard of care for metastatic renal cell carcinoma?. Clin Genitourin Cancer 4 (2005) 181
-
(2005)
Clin Genitourin Cancer
, vol.4
, pp. 181
-
-
Hutson, T.E.1
Quinn, D.I.2
-
3
-
-
33947288597
-
Vascular endothelial growth factor-targeted therapy in renal cell carcinoma: current status and future directions
-
Rini B.I. Vascular endothelial growth factor-targeted therapy in renal cell carcinoma: current status and future directions. Clin Cancer Res 13 (2007) 1098
-
(2007)
Clin Cancer Res
, vol.13
, pp. 1098
-
-
Rini, B.I.1
-
4
-
-
13644251904
-
Advances in imaging mouse tumour models in vivo
-
Lyons S.K. Advances in imaging mouse tumour models in vivo. J Pathol 205 (2005) 194
-
(2005)
J Pathol
, vol.205
, pp. 194
-
-
Lyons, S.K.1
-
5
-
-
0028938743
-
Cellular and molecular studies in the treatment of murine renal cancer
-
Wiltrout R.H., Gregorio T.A., Fenton R.G., et al. Cellular and molecular studies in the treatment of murine renal cancer. Semin Oncol 22 (1995) 9
-
(1995)
Semin Oncol
, vol.22
, pp. 9
-
-
Wiltrout, R.H.1
Gregorio, T.A.2
Fenton, R.G.3
-
6
-
-
11144307438
-
Monitoring luciferase-labeled cancer cell growth and metastasis in different in vivo models
-
Nogawa M., Yuasa T., Kimura S., et al. Monitoring luciferase-labeled cancer cell growth and metastasis in different in vivo models. Cancer Lett 217 (2005) 243
-
(2005)
Cancer Lett
, vol.217
, pp. 243
-
-
Nogawa, M.1
Yuasa, T.2
Kimura, S.3
-
7
-
-
34547093162
-
Vascular endothelial growth factor trap blocks tumor growth, metastasis formation, and vascular leakage in an orthotopic murine renal cell cancer model
-
Verheul H.M., Hammers H., van Erp K., et al. Vascular endothelial growth factor trap blocks tumor growth, metastasis formation, and vascular leakage in an orthotopic murine renal cell cancer model. Clin Cancer Res 13 (2007) 4201
-
(2007)
Clin Cancer Res
, vol.13
, pp. 4201
-
-
Verheul, H.M.1
Hammers, H.2
van Erp, K.3
-
8
-
-
34547653955
-
Synergistic in vivo antitumor effect of the histone deacetylase inhibitor MS-275 in combination with interleukin 2 in a murine model of renal cell carcinoma
-
Kato Y., Yoshimura K., Shin T., et al. Synergistic in vivo antitumor effect of the histone deacetylase inhibitor MS-275 in combination with interleukin 2 in a murine model of renal cell carcinoma. Clin Cancer Res 13 (2007) 4538
-
(2007)
Clin Cancer Res
, vol.13
, pp. 4538
-
-
Kato, Y.1
Yoshimura, K.2
Shin, T.3
-
9
-
-
0002282027
-
Nephrotoxicity and induction of the renal adenocarcinoma by ferric-nitrilotriacetate (Fe-NTA) in rats
-
Urushizaki I. (Ed), Elsevier Science, Amsterdam
-
Okada S., Hamazaki S., Ebina Y., et al. Nephrotoxicity and induction of the renal adenocarcinoma by ferric-nitrilotriacetate (Fe-NTA) in rats. In: Urushizaki I. (Ed). Structure and Function of Iron Storage and Transport Proteins (1983), Elsevier Science, Amsterdam 473-478
-
(1983)
Structure and Function of Iron Storage and Transport Proteins
, pp. 473-478
-
-
Okada, S.1
Hamazaki, S.2
Ebina, Y.3
-
10
-
-
37349078679
-
Tissue-targeted in vivo gene transfer coupled with histone deacetylase inhibitor depsipeptide (FK228) enhances adenoviral infection in rat renal cancer allograft model systems
-
Kobayashi M., Okada T., Murakami T., et al. Tissue-targeted in vivo gene transfer coupled with histone deacetylase inhibitor depsipeptide (FK228) enhances adenoviral infection in rat renal cancer allograft model systems. Urology 70 (2007) 1230
-
(2007)
Urology
, vol.70
, pp. 1230
-
-
Kobayashi, M.1
Okada, T.2
Murakami, T.3
-
11
-
-
0142106013
-
Tumor immunotherapy by converting tumor cells to MHC class II-positive, Ii protein-negative phenotype
-
Lu X., Kallinteris N.L., Li J., et al. Tumor immunotherapy by converting tumor cells to MHC class II-positive, Ii protein-negative phenotype. Cancer Immunol Immunother 52 (2003) 592
-
(2003)
Cancer Immunol Immunother
, vol.52
, pp. 592
-
-
Lu, X.1
Kallinteris, N.L.2
Li, J.3
-
12
-
-
0346250110
-
Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis
-
Jenkins D.E., Oei Y., Hornig Y.S., et al. Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis. Clin Exp Metastasis 20 (2003) 733
-
(2003)
Clin Exp Metastasis
, vol.20
, pp. 733
-
-
Jenkins, D.E.1
Oei, Y.2
Hornig, Y.S.3
-
13
-
-
0034486139
-
Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging
-
Rehemtulla A., Stegman L.D., Cardozo S.J., et al. Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia 2 (2000) 491
-
(2000)
Neoplasia
, vol.2
, pp. 491
-
-
Rehemtulla, A.1
Stegman, L.D.2
Cardozo, S.J.3
-
14
-
-
33646413674
-
In vitro validation of bioluminescent monitoring of disease progression and therapeutic response in leukaemia model animals
-
Inoue Y., Tojo A., Sekine R., et al. In vitro validation of bioluminescent monitoring of disease progression and therapeutic response in leukaemia model animals. Eur J Nucl Med Mol Imaging 33 (2006) 557
-
(2006)
Eur J Nucl Med Mol Imaging
, vol.33
, pp. 557
-
-
Inoue, Y.1
Tojo, A.2
Sekine, R.3
-
15
-
-
0030586549
-
Th1-associated immune responses to beta-galactosidase expressed by a replication-defective herpes simplex virus
-
Brubaker J.O., Thompson C.M., Morrison L.A., et al. Th1-associated immune responses to beta-galactosidase expressed by a replication-defective herpes simplex virus. J Immunol 157 (1996) 1598
-
(1996)
J Immunol
, vol.157
, pp. 1598
-
-
Brubaker, J.O.1
Thompson, C.M.2
Morrison, L.A.3
-
16
-
-
0034502576
-
Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-Kd-restricted CTL epitope
-
Gambotto A., Dworacki G., Cicinnati V., et al. Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-Kd-restricted CTL epitope. Gene Ther 7 (2000) 2036
-
(2000)
Gene Ther
, vol.7
, pp. 2036
-
-
Gambotto, A.1
Dworacki, G.2
Cicinnati, V.3
-
17
-
-
33646817731
-
"Firefly rats" as an organ/cellular source for long-term in vivo bioluminescent imaging
-
Hakamata Y., Murakami T., and Kobayashi E. "Firefly rats" as an organ/cellular source for long-term in vivo bioluminescent imaging. Transplantation 81 (2006) 1179
-
(2006)
Transplantation
, vol.81
, pp. 1179
-
-
Hakamata, Y.1
Murakami, T.2
Kobayashi, E.3
-
18
-
-
34548212756
-
Immune response to firefly luciferase as a naked DNA
-
Jeon Y.H., Choi Y., Kang J.H., et al. Immune response to firefly luciferase as a naked DNA. Cancer Biol Ther 6 (2007) 781
-
(2007)
Cancer Biol Ther
, vol.6
, pp. 781
-
-
Jeon, Y.H.1
Choi, Y.2
Kang, J.H.3
-
19
-
-
55749089404
-
Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer
-
Rabinovich B.A., Ye Y., Etto T., et al. Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer. Proc Natl Acad Sci U S A 105 (2008) 14342
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, pp. 14342
-
-
Rabinovich, B.A.1
Ye, Y.2
Etto, T.3
-
20
-
-
34248208100
-
A novel bioluminescent tumor model of human renal cancer cell lines: an in vitro and in vivo characterization
-
Peter C., Kielstein J.T., Clarke-Katzenberg R., et al. A novel bioluminescent tumor model of human renal cancer cell lines: an in vitro and in vivo characterization. J Urol 177 (2007) 2342
-
(2007)
J Urol
, vol.177
, pp. 2342
-
-
Peter, C.1
Kielstein, J.T.2
Clarke-Katzenberg, R.3
-
21
-
-
8844225001
-
Validation of bioluminescence imaging of colorectal liver metastases in the mouse
-
Smakman N., Martens A., Kranenburg O., et al. Validation of bioluminescence imaging of colorectal liver metastases in the mouse. J Surg Res 122 (2004) 225
-
(2004)
J Surg Res
, vol.122
, pp. 225
-
-
Smakman, N.1
Martens, A.2
Kranenburg, O.3
-
22
-
-
33747691089
-
A phase II trial of 17-(Allylamino)-17-demethoxygeldanamycin in patients with papillary and clear cell renal cell carcinoma
-
Ronnen E.A., Kondagunta G.V., Ishill N., et al. A phase II trial of 17-(Allylamino)-17-demethoxygeldanamycin in patients with papillary and clear cell renal cell carcinoma. Invest New Drugs 24 (2006) 543
-
(2006)
Invest New Drugs
, vol.24
, pp. 543
-
-
Ronnen, E.A.1
Kondagunta, G.V.2
Ishill, N.3
-
23
-
-
41449107739
-
c-Met inhibitors with novel binding mode show activity against several hereditary papillary renal cell carcinoma-related mutations
-
Bellon S.F., Kaplan-Lefko P., Yang Y., et al. c-Met inhibitors with novel binding mode show activity against several hereditary papillary renal cell carcinoma-related mutations. J Biol Chem 283 (2008) 2675
-
(2008)
J Biol Chem
, vol.283
, pp. 2675
-
-
Bellon, S.F.1
Kaplan-Lefko, P.2
Yang, Y.3
|